Opendata, web and dolomites

ImmuNiche SIGNED

Identifying spatial determinants of immune cell fate commitment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ImmuNiche project word cloud

Explore the words cloud of the ImmuNiche project. It provides you a very rough idea of what is the project "ImmuNiche" about.

localization    types    spatial    poorly    pathogenesis    expression    cytokine    patients    seq    multiplexed    leukaemia    reference    bone    functionally    treatment    malignant    mammalian    jointly    microenvironmental    commitment    sections    preferential    rna    250    patient    murine    mouse    prognosis    strategy    predict    giving    tissue    tissues    differentiation    conserved    blood    trajectories    model    globally    interactions    fluorescent    molecular    resolution    resident    sub    fate    cell    marrow    progenitor    mds    models    composition    regulators    underlying    syndromes    compare    mechanisms    decades    frequent    combination    blueprint    single    conservation    stem    niche    normal    computational    predicted    cutting    hematopoietic    reveal    microenvrionmental    cells    myelodysplastic    signals    integrating    edge    malignancies    hybridization    donors    disease    niches    molecule    gene    determinants    mice    architecture    few    situ    pinpoint    co    poor    human    microenvironment    therapeutic    visualizing    prevention    techniques    resolve    healthy    markers    representing   

Project "ImmuNiche" data sheet

The following table provides information about the project.

Coordinator
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV 

Organization address
address: HOFGARTENSTRASSE 8
city: MUENCHEN
postcode: 80539
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙997˙500 €
 EC max contribution 1˙997˙500 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2024-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV DE (MUENCHEN) coordinator 1˙997˙500.00

Map

 Project objective

The complex architecture of the mammalian hematopoietic system has been studied for decades, yet the molecular mechanisms underlying cell fate commitment remain poorly understood. Although cytokine signals are major determinants of hematopoietic cell fate, only few niches of stem and progenitor cells have been characterized. Here, we propose to resolve the cell type composition of mouse bone marrow by integrating single-cell RNA-seq with high-resolution spatial analysis of gene expression in tissue sections, visualizing ~250 cell type specific markers by multiplexed single-molecule RNA fluorescent in situ hybridization. This approach will reveal preferential co-localization of hematopoietic cells with other bone marrow-resident cell types, and globally predict niches of hematopoietic progenitor sub-types to pinpoint microenvrionmental determinants of hematopoietic cell fate. Based on this reference we will investigate the role of the microenvironment in the pathogenesis of myelodysplastic syndromes (MDS), representing one of the most frequent blood cell malignancies, commonly giving rise to leukaemia with poor prognosis. To investigate conservation of microenvironmental determinants of normal and malignant hematopoietic differentiation in human, we will apply the same strategy to healthy donors and human MDS patients and compare predicted cell types, differentiation trajectories, and niche interactions to those derived from healthy mice and murine MDS models. This approach will reveal conserved niche regulators of cell fate commitment involved in disease pathogenesis, which we will functionally analyse in murine models to identify novel therapeutic targets for prevention and treatment of MDS. Our approach represents a blueprint for investigating human malignancies of under-characterized tissues by applying cutting-edge high-resolution techniques in combination with advanced computational methods to jointly analyse the murine model and human patient microenvironment.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMMUNICHE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMMUNICHE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CHIPTRANSFORM (2018)

On-chip optical communication with transformation optics

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More  

AST (2019)

Automatic System Testing

Read More